SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines. Learn more.
Wall Street Journal: Startup Hunts for a Better Duchenne Gene Therapy. SonoThera raises $125 million to run clinical trials of its gene treatment for Duchenne muscular dystrophy.